Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cellsIvan Cohen, Kostas Stamatopoulos, Jean Lemoine et al.|Science Translational Medicine|2026Cited by 10